Ensuring trust in AI/ML when used in pharmacovigilance – New podcast episode

Technology / 27 June 2024

Ensuring trust in AI is vital to fully reap the benefits of the technology in pharmacovigilance. Yet, how do we do so while grappling with its ever-growing complexity?


According to Michael Glaser, the Safety Innovation Technology Director at GSK, the answer lies in a mindset shift in how we think about validating AI and machine learning, and coming together to discuss how we move forward in the implementation of this technology in healthcare.

This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. Subscribe by visiting the Drug Safety Matters website.

Related Articles

How do we ensure trust in AI/ML when used in pharmacovigilance?

VigiFlow eReporting for Industry increases the ‘flow’ of communication between industry and regulators

The power of going digital: HSA ADR News Bulletin now reaches more readers

You may also like

VigiFlow eReporting for Industry increases the ‘flow’ of communication between industry and regulators

Since implementing this module into its safety reporting process, INVIMA has seen marked improvements in the quality, quantity, and timeliness of reports sent to VigiBase.

Technology / 14 February 2024

The power of going digital: HSA ADR News Bulletin now reaches more readers

To reach more readers, the HSA undertook a digitalisation project of their news bulletin for communicating signal data. The results reveal the impact of going digital.

Technology / 17 May 2023

How do we ensure trust in AI/ML when used in pharmacovigilance?

Ensuring trust in AI is paramount to fully reap the benefits of the technology in pharmacovigilance. Yet, how do we do so while grappling with its ever-growing complexity?

Technology / 26 February 2024